Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

'Often Reserved' FDA Biologics Chief Midthun To Depart

This article was originally published in Scrip

Executive Summary

Karen Midthun, director of the FDA's Center for Biologics Evaluation and Research (CBER), is retiring from the agency, acting Commissioner Stephen Ostroff and his intended successor, Robert Califf, deputy commissioner for medical products and tobacco, confirmed to their staff on Oct. 2, declaring they had "mixed emotions" about her departure.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register